QIAGEN N.V. (QGEN) stock
QGENNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$49.75−0.06 (-0.12%)
Close on Nov 17, 2026Market cap $10.79BP/E 25.6Yield 0.50%
Qiagen total assets
Total assets on the balance sheet at the end of each period.
Qiagen's total assets was $6.28B at Dec 31, 2025. For fiscal 2025 it was $6.28B, up 10.4% from the year before. Over ten years it grew 4.2% a year on average. The highest annual figure on record is $6.29B in fiscal 2022.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.28B | +10.4% |
| FY2024 | Dec 31, 2024 | $5.69B | -7.0% |
| FY2023 | Dec 31, 2023 | $6.12B | -2.7% |
| FY2022 | Dec 31, 2022 | $6.29B | +2.3% |
| FY2021 | Dec 31, 2021 | $6.15B | +4.7% |
| FY2020 | Dec 31, 2020 | $5.87B | +12.1% |
| FY2019 | Dec 31, 2019 | $5.24B | -8.9% |
| FY2018 | Dec 31, 2018 | $5.75B | +14.1% |
| FY2017 | Dec 31, 2017 | $5.04B | +17.0% |
| FY2016 | Dec 31, 2016 | $4.31B | +3.1% |
| FY2015 | Dec 31, 2015 | $4.18B | -6.2% |
| FY2014 | Dec 31, 2014 | $4.45B | +9.0% |
| FY2013 | Dec 31, 2013 | $4.09B | +0.0% |
| FY2012 | Dec 31, 2012 | $4.09B | +9.6% |
| FY2011 | Dec 31, 2011 | $3.73B | -4.7% |
| FY2010 | Dec 31, 2010 | $3.91B | +3.1% |
| FY2009 | Dec 31, 2009 | $3.80B | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2025 | Dec 31, 2025 | $6.28B | +2.2% |
| Q4 FY2024 | Dec 31, 2024 | $5.69B | -3.1% |
| Q4 FY2023 | Dec 31, 2023 | $6.12B | +16.8% |
| Q4 FY2022 | Dec 31, 2022 | $6.29B | +9.4% |
| Q4 FY2021 | Dec 31, 2021 | $6.15B | +22.0% |
| Q4 FY2020 | Dec 31, 2020 | $5.87B | +36.2% |
| Q4 FY2019 | Dec 31, 2019 | $5.24B | +25.3% |
| Q4 FY2018 | Dec 31, 2018 | $5.75B | +29.0% |
| Q4 FY2017 | Dec 31, 2017 | $5.04B | +23.2% |
| Q4 FY2016 | Dec 31, 2016 | $4.31B | +5.4% |
| Q4 FY2015 | Dec 31, 2015 | $4.18B | +12.1% |
| Q4 FY2014 | Dec 31, 2014 | $4.45B | +13.8% |
| Q4 FY2013 | Dec 31, 2013 | $4.09B | +7.7% |
| Q4 FY2012 | Dec 31, 2012 | $4.09B | – |
| Q4 FY2011 | Dec 31, 2011 | $3.73B | – |
| Q4 FY2010 | Dec 31, 2010 | $3.91B | – |
| Q4 FY2009 | Dec 31, 2009 | $3.80B | – |
See a number that looks wrong?